Objectives: The objective of this study was to assess the effectiveness of government regulation of private pharmacy practice in a low-income country.
Methods: The intervention comprised inspections of the pharmacies, information, and distribution of documents to drug sellers and sanctions. It was implemented at two different intensity levels, active and regular intervention. The methods used to assess the effect of the interventions were interviews with the district drug inspectors, drug sellers and customers, inspection of drug purchases, and indicator surveys of pharmacies. Indicators for pharmacy-specific quality as well as for dispensing quality were developed.
Results: The main finding was one of strong overall improvements from initially low levels. The improvements were particularly marked by increases in the availability of essential materials for dispensing by 34% and in order in the pharmacy by 19%. Information given to customers increased from 35% to 51% and the mixing of different drugs in the same package went down from 17% to 9%. The pharmacies in the active intervention districts showed greater improvements for four of the six indicators, although statistically significant compared with the regular intervention districts only for the essential materials indicator.
Conclusions: It was concluded that the regulatory activities have probably been an important factor behind the service quality improvements. It appeared feasible as well as effective to regulate private pharmacy practice in this particular low-income setting.
Download full-text PDF |
Source |
---|
BBA Adv
December 2024
Genos Glycoscience Research Laboratory, 10000 Zagreb, Croatia.
Down syndrome (DS), a genetic condition caused by trisomy 21 (T21), manifests various neurological symptoms, including intellectual disability, early neurodegeneration, and early-onset dementia. N-glycosylation is a protein modification that plays a critical role in numerous neurobiological processes and whose dysregulation is associated with a range of neurological disorders. However, whether N-glycosylation of neural glycoproteins is affected in DS has not been studied.
View Article and Find Full Text PDFBMC Public Health
January 2025
School of Population Health, National Institute for Health Innovation, The University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.
Animal Model Exp Med
January 2025
Department of Pharmacy, Faculty of Health and Life Sciences, Daffodil International University, Daffodil Smart City, Bangladesh.
Background: Neurodegenerative diseases (NDs), including Alzheimer's disease, Parkinson's disease, and Huntington's disease, are complex and challenging due to their intricate pathophysiology and limited treatment options.
Methods: This review systematically sourced articles related to neurodegenerative diseases, neurodegeneration, quercetin, and clinical studies from primary medical databases, including Scopus, PubMed, and Web of Science.
Results: Recent studies have included quercetin to impact the cellular and molecular pathways involved in neurodegeneration.
Int Dent J
January 2025
Department of Endodontics, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Introduction: Artificial intelligence (AI), including its subfields of machine learning and deep learning, is a branch of computer science and engineering focused on creating machines capable of tasks requiring human-like intelligence, such as visual perception, decision-making, and natural language processing. AI applications have become increasingly prevalent in dental medicine, generating high expectations as well as raising ethical and practical concerns.
Methods: This critical review evaluates the current applications of AI in dentistry, identifying key perspectives, challenges, and limitations in ongoing AI research.
Vaccine
January 2025
Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI, USA.
Background: Substantial investments by government programs and private health plans subsidized the costs of COVID-19 vaccine doses and vaccine administration. The objective of this study was to evaluate the cost-effectiveness of vaccination against COVID-19 illness during the initial year of COVID-19 vaccination (2021).
Methods: Using a simulation model, we projected outcomes for hypothetical cohorts of US adults aged 18 and older, stratified by age and risk status for complications, comparing vaccination and no vaccination in the context of recommended concomitant prevention strategies (e.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!